News &amp; Updates

Vitamin D supplementation appears to improve inflammatory bowel disease (IBD) outcomes, including related ED visits, hospitalizations, and corticosteroid use, according to a retrospective study.

Vitamin D supplementation offers some benefits in IBD

GLP-1 RAs up risks of GERD, complication vs SGLT-2 inhibitors

Compared with using SGLT-2 inhibitors, treatment with GLP-1 receptor agonists (RAs) may increase the risk for gastroesophageal reflux disease (GERD) and its complications in patients with type 2 diabetes (T2D), a recent study has shown.

GLP-1 RAs up risks of GERD, complication vs SGLT-2 inhibitors

Tulisokibart looks good for Crohn’s disease

19 Jul 2025

Induction treatment with the anti-TL1A monoclonal antibody tulisokibart appears to produce response in patients with moderately to severely active Crohn’s disease (CD) while being well tolerated, according to the results of a phase IIa trial.

Tulisokibart looks good for Crohn’s disease

19 Jul 2025

Coeliac disease risk increased among patient kin

17 Jul 2025

First-degree relatives (FDRs) of patients with coeliac disease (CD) are at an elevated risk of developing CD, suggests a study.

Coeliac disease risk increased among patient kin

17 Jul 2025

Hepatic steatosis linked to lower mortality in CLD patients

The presence of substantial hepatic steatosis estimated by controlled attenuated parameter (CAP) score among patients who underwent vibration-controlled transient elastography (VCTE) appears to reduce the risk of all-cause mortality and decompensation, particularly in those with metabolic dysfunction-associated steatotic liver disease (MASLD), reports a study.

Hepatic steatosis linked to lower mortality in CLD patients

Ustekinumab improves outcomes in UC patients

Treatment with ustekinumab can help patients with ulcerative colitis (UC) achieve clinical and endoscopic outcomes of importance after 12 months, results of a real-world study have shown.

Ustekinumab improves outcomes in UC patients

Nontargeted better than targeted screening at identifying HCV cases in EDs

14 Jul 2025 by

A non–risk-based screening approach for hepatitis C virus (HCV) infection in the emergency department (ED), where all eligible patients were offered rapid testing, improves the identification of new infections when compared with a targeted approach of narrowly focusing on at-risk groups, according to the DETECT Hep C trial.

Nontargeted better than targeted screening at identifying HCV cases in EDs

14 Jul 2025

Patency capsule retention tied to small bowel disease in CD

In patients with Crohn’s disease (CD), retention of both patency capsules and video capsule endoscopy (VCE) is significantly associated with small bowel disease on imaging scans, suggests a study.

Patency capsule retention tied to small bowel disease in CD

Aspirin use may prevent CRC metastasis

The use of aspirin appears to provide protective benefits against metastasis in patients with colorectal cancer (CRC), reports a study.

Aspirin use may prevent CRC metastasis